• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.60% Nasdaq Down 0.39%

    OncoMed Pharmaceuticals, Inc. (OMED)

    -NasdaqGS
    9.04 Up 0.06(0.67%) 4:00PM EST
    Prev Close:8.98
    Open:10.05
    Bid:9.05 x 100
    Ask:9.07 x 700
    1y Target Est:18.40
    Beta:2.06729
    Earnings Date:Mar 7 - Mar 11 (Est.)
    Day's Range:8.90 - 10.10
    52wk Range:8.54 - 29.83
    Volume:342,656
    Avg Vol (3m):281,485
    Market Cap:272.18M
    P/E (ttm):N/A
    EPS (ttm):-2.53
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OMEDUp 0.67%272.18M
    STMLUp 3.65%76.68M
    VSTMUp 0.89%41.74M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.80
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.59
    Quarterly EPS Est (Dec-15) :0.41
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    OncoMed Pharmaceuticals, Inc., a clinical development-stage biotechnology company, discovers and develops protein therapeutics targeting cancer stem cells (CSCs). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback